Rivaroxaban for Thromboprophylaxis Reply

被引：0
|
作者：
Geerts, William [1 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 359卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2175 / 2175
页数：1
相关论文
共 50 条
  • [31] Apixaban or Enoxaparin for Thromboprophylaxis REPLY
    Lassen, Michael Rud
    Raskob, Gary E.
    Gallus, Alexander
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (21): : 2101 - 2101
  • [32] Thromboprophylaxis in hip arthroplasty - Reply
    Comp, PC
    Spiro, TE
    Friedman, RJ
    Whitsett, TL
    Johnson, GJ
    Gardiner, GA
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (05): : 877 - 877
  • [33] Thromboprophylaxis and regional anesthesia - Reply
    Wu, CL
    Perkins, FM
    REGIONAL ANESTHESIA, 1997, 22 (06) : 589 - 590
  • [34] Rivaroxaban, an Oral, Direct Factor Xa Inhibitor: A New Option for Thromboprophylaxis
    Kwong, Louis M.
    ORTHOPEDICS, 2012, 35 (11) : 919 - 919
  • [35] Safety and efficacy of rivaroxaban for thromboprophylaxis following lower limb surgery: an update
    Goff, Thomas
    Kontakis, George
    Giannoudis, Peter V.
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (05) : 687 - 696
  • [36] Thromboprophylaxis by rivaroxaban, aspirin, both, or placebo after hospitalization for medical illness
    Tomkowski, Witold Z.
    Davidson, Bruce L.
    THROMBOSIS RESEARCH, 2019, 180 : 62 - 63
  • [37] Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement
    Cheallaigh, Sadhbh Ni
    Fleming, Aoife
    Dahly, Darren
    Kehoe, Eimear
    O'Byrne, John M.
    McGrath, Brid
    O'Connell, Charles
    Sahm, Laura J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (03) : 853 - 860
  • [38] Rivaroxaban superior to Nadroparin for thromboprophylaxis in patients receiving hip or knee arthroplasty
    Heckmann, M. B.
    Hillebrand, I
    Silay, H.
    Thermann, H.
    Siebold, R.
    Klonz, A.
    Gruber, G.
    Scheller, G.
    Heckmann, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 822 - 823
  • [39] Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement
    Sadhbh Ní Cheallaigh
    Aoife Fleming
    Darren Dahly
    Eimear Kehoe
    John M. O’Byrne
    Brid McGrath
    Charles O’Connell
    Laura J. Sahm
    International Journal of Clinical Pharmacy, 2020, 42 : 853 - 860
  • [40] Rivaroxaban, an Oral, Direct Factor Xa Inhibitor: A New Option for Thromboprophylaxis
    Kwong, Louis M.
    ORTHOPEDICS, 2012, 35 (06) : E932 - E938
12345